Eyecare biotech jumps 19% after stablecoin-focused pivot
NovaBay Pharmaceuticals was founded in 2000 as a biopharmaceutical company developing eye care products and is now betting big on the Sky protocol and stablecoins.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
NovaBay Pharmaceuticals was founded in 2000 as a biopharmaceutical company developing eye care products and is now betting big on the Sky protocol and stablecoins.
Why this matters
This maps to the Stablecoins hub, so it can help confirm whether that theme is gaining breadth across the crypto news cycle.
Original source
Read on CointelegraphRelated market context
Securitize Teams With Korea’s LG CNS to Explore Tokenized Funds and Stablecoins
Securitize and Korean technology company LG CNS announced a strategic partnership, set out in a memorandum of understanding, aimed...
EU crypto platforms given 3 months to remove unauthorized stablecoins
The ESMA's directive may reshape EU crypto markets by limiting non-compliant stablecoins, potentially altering global regulatory t...
Money20/20 USA 2026: How Bitcoin, Stablecoins and AI Are Reshaping the Future of Finance
Bitcoin Magazine Money20/20 USA 2026: How Bitcoin, Stablecoins and AI Are Reshaping the Future of Finance Fintech has moved beyond...
ESMA orders MiCA firms to halt services for non-compliant stablecoins
The EU's deadline for crypto firms to drop non-compliant stablecoins like USDT may reshape market dynamics and regulatory strategi...
Cardano Foundation spins out Veridian as an independent digital identity company
Veridian's independence could accelerate digital identity innovation, impacting global security, privacy standards, and blockchain...
ESMA gives crypto firms 3 months to exit non-compliant stablecoins
ESMA urged EU crypto firms to halt services involving non-MiCA-compliant stablecoins, giving regulators three months to address ex...